The Valiant Laboratories IPO date has been confirmed from September 27 and ended on October 3 .
The IPO date for Valiant Laboratories IPO has been confirmed; the IPO is expected to go public on November 9 and close on November 11. Valiant Laboratories IPO Technologies IPO will raise approximately 1960 crores through an IPO that will include a fresh issue of [.] crores and an offer for sale of up to 1960 crores of 1 each. The retail share is 35%, the QIB share is 50%, and the HNI share is 15%.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Sep 27 – Oct 3, 2023
Price Range
₹133 to ₹140 per share
Face Value
₹10 per share
GMP
₹20
Valiant Laboratories IPO GMP
The Valiant Laboratories IPO GMP is ₹[20].
IPO Overview
The price range for Valiant Laboratories’ IPO has been established at ₹133 to ₹140 per share. Retail investors are required to invest a minimum amount of ₹14,700, with a minimum lot size of 105 shares. As for sNII, the minimum lot size investment is 14 lots (1,470 shares), totaling ₹205,800. On the other hand, bNII has a minimum lot size investment of 69 lots (7,245 shares), amounting to ₹1,014,300. Manufacturing facility is located at Plot nos. L-13 and L-30, Tarapur Industrial Area, Boisar, Palghar, 401506, in the state of Maharashtra, India and is spread over an aggregate parcel of land measuring about 2,000 sq. mts. with an aggregate annual total installed capacity of 9,000 MT per annum. Their Manufacturing Facility employs modern machinery and equipment to ensure a smooth flow of operations. As of the date of this Draft Red Herring
Valiant Laboratories IPO Date & Price Band Details
| IPO Date | September 27, 2023 to October 3, 2023 |
| Listing Date | October 6, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹133 to ₹140 per share |
| Lot Size | 105 Shares |
| Total Issue Size | 10,890,000 shares (aggregating up to ₹152.46 Cr) |
| Fresh Issue | 10,890,000 shares (aggregating up to ₹152.46 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 32,560,000 |
| Share holding post issue | 43,450,000 |
Valiant Laboratories IPO Market Lot
The IPO of Valiant Laboratories IPO has a minimum market lot of 31 shares, requiring an application amount of ₹14,694. Retail investors have the opportunity to apply for a maximum of 13 lots, which amounts to 403 shares or ₹191,022.
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1365 | ₹191,100 |
| S-HNI (Min) | 14 | 1,470 | ₹205,800 |
| S-HNI (Max) | 68 | 7,140 | ₹999,600 |
| B-HNI (Min) | 69 | 7,245 | ₹1,014,300 |
Valiant Laboratories IPO Allotment and Listing Dates
| IPO Open Date | Wednesday, September 27, 2023 |
| IPO Close Date | Tuesday, October 3, 2023 |
| Basis of Allotment | Thursday, October 5, 2023 |
| Initiation of Refunds | Friday, October 6, 2023 |
| Credit of Shares to Demat | Friday, October 6, 2023 |
| Listing Date | Friday, October 6, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on October 3, 2023 |
Valiant Laboratories IPO Company Financial Report
| IPO Open: | September 27, 2023 |
| IPO Close: | October 3, 2023 |
| IPO Size: | Approx ₹[.] Crores |
| Fresh Issue: | Approx 11,556,000 shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹[.] to ₹[.] Per Share |
| IPO Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Discount: | N/A |
Company Profile
Established in 1984, Valiant Laboratories IPO Limited is a Non-Banking Finance Company (NBFC-ND-SI) that specializes in providing secured business loans to micro-entrepreneurs and self-employed individuals. With a vast network of 311 branches across eight states and one union territory, as well as approximately 150 districts throughout India, the company has established a strong presence in Tamil Nadu, Andhra Pradesh, Telangana, and Karnataka. Valiant Laboratories IPO Limited has developed a unique business model that revolves around identifying an appropriate risk framework and determining the
ideal instalment-to-income ratio. This approach ensures that customers have the necessary resources to repay their loans while fulfilling their regular obligations and addressing any event-based capital requirements. Headquartered in Chennai, Tamil Nadu, the company holds a prominent position in the southern region of India. As of September 30, 2021, Valiant Laboratories IPO Limited boasted a workforce of 4,306 dedicated employees.
Registrar Info
| Name | LINK INTIME INDIA PRIVATE LIMITED |
| Phone number | +91-22-4918 6270 |
| Email ID | valiantlaboratories.ipo@linkintime.co.in |
| Website | https://valiantlabs.in/ |
Contact Details
| Name | Valiant Laboratories |
| Phone number | +91 22497 12001 |
| Email ID | complianceofficer@valiantlabs.in |
| Website | https://valiantlabs.in/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
